More tools:Markets·Screener·Research·Chat

bioAffinity Technologies, Inc. Common Stock (BIAF) Financial Statements

bioAffinity Technologies, Inc. Common Stock
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG00H69JDY0
XNAS · usd
8.93▼ 6.34 (-41.52%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close15.27
Day's Range8.36 – 10.63
52-Week Range0.13 – 20.35
Volume2.4M
Avg Volume10.3M
Share Statistics
Shares Outstanding
Employees57
ExchangeXNAS
Listed2022-09-01
Share count as of August 3, 2026
Loading Income Statement…
Key questions about bioAffinity Technologies, Inc. Common Stock (BIAF)
What is bioAffinity Technologies, Inc. Common Stock's Market Cap?
bioAffinity Technologies, Inc. Common Stock's Market Cap is $72.3M, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's Enterprise Value?
bioAffinity Technologies, Inc. Common Stock's Enterprise Value is $70.5M, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's Price / Sales?
bioAffinity Technologies, Inc. Common Stock's Price / Sales is 12.3×, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's EV / Revenue?
bioAffinity Technologies, Inc. Common Stock's EV / Revenue is 11.9×, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's EV / EBITDA?
bioAffinity Technologies, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's Revenue (TTM)?
bioAffinity Technologies, Inc. Common Stock's Revenue (TTM) is $5.9M, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's Net Income (TTM)?
bioAffinity Technologies, Inc. Common Stock's Net Income (TTM) is -$15.2M, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's EBITDA?
bioAffinity Technologies, Inc. Common Stock's EBITDA is -$12.0M, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's Diluted EPS (TTM)?
bioAffinity Technologies, Inc. Common Stock's Diluted EPS (TTM) is -1.87, based on as-reported figures from SEC (XBRL) filings.
What is bioAffinity Technologies, Inc. Common Stock's EBITDA Margin?
bioAffinity Technologies, Inc. Common Stock's EBITDA Margin is -202.8%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Patient services fees
YoY growth+19.0%-27.1%-27.8%-38.5%
Operating expenses:
Total Operating Expenses
Research and Development Expense
Clinical development
Selling, General and Administrative Expense
Depreciation Expense
Loss from operations
% of revenue-220.8%-267.6%-196.9%-158.6%
Other income (expense):
Interest and Dividend Income (Non-Bank)
Interest expense
Non-Operating Income (Expense)—
Other expense
Change in fair value of warrants issued——
Total other income (expense), net—
Net loss before provision for income tax expense
Net loss
% of revenue-222.8%-268.6%-197.0%-349.3%
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—